Filings & corporate actions
- 19 NovdividendDividend · ₹1.25 per share · record 19 Nov 2026+0.2%
- 13 NovresultsResults · Q2 FY27 · consolidated and standalone+0.2%NSE
- 1 NovshareholdingShareholding · 23 Oct 2026+0.4%NSE
- 16 OctshareholdingShareholding · 30 Sept 20260.0%NSE
- 1 OctrightsRights 2:21 @ Premium Rs 748/- · record 1 Oct 2026-0.7%
- 20 AugdividendDividend · ₹1.50 per share-1.1%
- 14 AugresultsResults · Q1 FY27 · consolidated and standalone-1.5%NSE
- 9 JulshareholdingShareholding · 30 Jun 2026-0.5%NSE
- 29 MayresultsResults · Q4 FY26 · consolidated and standalone-8.1%NSE
- 9 AprshareholdingShareholding · 31 Mar 2026+1.0%NSE
- 18 FebdividendDividend · ₹1.50 per share+0.7%
- 12 FebresultsResults · Q3 FY26 · consolidated and standalone-1.9%NSE
- 19 JanshareholdingShareholding · 31 Dec 2025-1.6%NSE
Reaction to results · all yearsrose on day 0 in 28 of 79 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q2 FY27 | 13 Nov 2026 | +0.2% | +0.7% | — | 6.5× |
| Q1 FY27 | 14 Aug 2026 | -1.5% | -2.1% | -9.3% | 1.9× |
| Q4 FY26 | 29 May 2026 | -8.1% | -14.5% | -8.3% | 3.9× |
| Q3 FY26 | 12 Feb 2026 | -1.9% | +6.2% | +12.7% | 0.9× |
| Q2 FY26 | 14 Nov 2025 | +1.0% | +3.5% | +11.4% | 1.2× |
| Q1 FY26 | 12 Aug 2025 | +1.8% | -0.8% | -2.9% | 0.5× |
| Q4 FY25 | 28 May 2025 | +3.6% | -0.1% | +1.0% | 6.8× |
| Q3 FY25 | 12 Feb 2025 | -20.0% | -34.9% | -34.3% | 18.2× |
| Q2 FY25 | 12 Nov 2024 | -1.7% | -2.4% | +3.7% | 4.4× |
| Q1 FY25 | 12 Aug 2024 | -1.3% | -1.5% | +6.5% | 1.5× |
| Q4 FY24 | 27 May 2024 | +0.3% | -5.7% | +14.4% | 9.9× |
| Q3 FY24 | 14 Feb 2024 | +0.3% | +14.0% | +10.5% | 2.6× |
| Q2 FY24 | 14 Nov 2023 | -4.5% | +0.7% | -3.7% | 4.2× |
| Q1 FY24 | 9 Aug 2023 | -2.0% | -3.2% | -1.3% | 1.5× |
| Q4 FY23 | 29 May 2023 | -2.1% | -2.0% | +8.3% | 1.8× |
| Q3 FY23 | 9 Feb 2023 | -0.9% | +1.0% | +2.8% | 0.9× |
| Q2 FY23 | 10 Nov 2022 | -0.7% | -2.4% | -3.4% | 1.8× |
| Q1 FY23 | 9 Aug 2022 | -10.3% | -13.0% | -19.8% | 8.5× |
| Q4 FY22 | 31 May 2022 | +3.7% | +3.7% | -3.9% | 14.3× |
| Q3 FY22 | 14 Feb 2022 | -2.4% | -8.4% | -8.5% | 3.6× |
| Q2 FY22 | 11 Nov 2021 | +0.6% | -1.9% | +7.2% | 1.5× |
| Q1 FY22 | 12 Aug 2021 | -5.1% | -13.4% | -6.3% | 0.9× |
| Q4 FY21 | 17 Jun 2021 | +1.2% | +1.3% | +2.4% | 1.0× |
| Q3 FY21 | 11 Feb 2021 | -3.6% | -8.1% | -6.7% | 3.6× |
| Q2 FY21 | 12 Nov 2020 | -0.6% | +0.5% | +4.5% | 2.6× |
| Q1 FY21 | 12 Aug 2020 | -4.2% | -1.2% | -8.2% | 0.8× |
| Q4 FY20 | 17 Jun 2020 | +1.0% | +3.7% | +11.8% | 0.7× |
| Q3 FY20 | 12 Feb 2020 | -4.9% | -6.5% | -20.9% | 3.7× |
| Q2 FY20 | 12 Nov 2019 | -3.2% | -4.1% | +0.6% | 2.0× |
| Q1 FY20 | 9 Aug 2019 | -0.6% | -2.1% | +3.1% | 1.4× |
| Q4 FY19 | 27 May 2019 | +0.9% | +3.3% | +2.2% | 8.6× |
| Q3 FY19 | 19 Feb 2019 | +1.1% | +0.9% | +2.8% | 1.0× |
| Q2 FY19 | 19 Nov 2018 | -1.7% | -4.1% | -4.9% | 1.1× |
| Q1 FY19 | 24 Aug 2018 | +1.0% | +3.3% | -0.7% | 0.8× |
| Q4 FY18 | 1 Jun 2018 | -1.0% | -2.6% | -0.3% | 1.6× |
| Q3 FY18 | 9 Feb 2018 | -1.9% | -3.1% | -10.2% | 0.9× |
| Q2 FY18 | 3 Nov 2017 | +0.2% | -2.4% | -1.0% | 1.0× |
| Q1 FY18 | 21 Aug 2017 | -4.4% | -4.4% | +5.7% | 0.4× |
| Q4 FY17 | 15 Jun 2017 | +2.1% | +0.4% | +2.0% | 2.0× |
| Q3 FY17 | 22 Feb 2017 | +4.5% | -0.4% | -0.5% | 2.8× |
| Q2 FY17 | 15 Nov 2016 | -2.6% | -9.9% | -9.9% | 2.4× |
| Q1 FY17 | 1 Oct 2016 | +0.4% | 0.0% | -1.7% | 1.7× |
| Q4 FY16 | 27 May 2016 | +0.2% | +11.7% | +23.8% | 4.9× |
| Q3 FY16 | 18 Feb 2016 | 0.0% | -3.8% | +2.3% | 0.5× |
| Q2 FY16 | 13 Nov 2015 | -0.1% | +5.4% | +11.3% | 0.7× |
| Q1 FY16 | 12 Aug 2015 | -5.6% | -3.3% | -9.6% | 1.6× |
| Q4 FY15 | 15 Jun 2015 | -0.8% | +7.3% | +12.6% | 0.4× |
| Q3 FY15 | 17 Feb 2015 | -0.1% | -3.2% | +54.3% | 0.2× |
| Q2 FY15 | 21 Nov 2014 | -1.7% | -1.3% | +0.9% | 0.8× |
| Q1 FY15 | 20 Aug 2014 | -1.1% | +7.3% | +33.2% | 0.8× |
| Q4 FY14 | 3 Jun 2014 | -1.1% | +7.2% | +33.2% | 0.3× |
| Q3 FY14 | 20 Feb 2014 | -1.1% | +7.8% | +4.4% | 0.5× |
| Q2 FY14 | 22 Nov 2013 | +1.5% | +1.3% | +6.5% | 0.7× |
| Q1 FY14 | 21 Aug 2013 | +1.2% | -0.2% | +5.2% | 0.6× |
| Q4 FY13 | 8 Jun 2013 | 0.0% | +3.7% | +6.9% | 0.2× |
| Q3 FY13 | 20 Feb 2013 | -0.5% | -4.0% | -1.9% | 0.1× |
| Q2 FY13 | 8 Nov 2012 | +2.5% | +5.4% | +22.2% | 8.2× |
| Q1 FY13 | 13 Aug 2012 | +1.7% | -3.2% | +4.9% | 1.1× |
| Q4 FY12 | 29 May 2012 | -1.8% | -9.7% | -15.3% | 1.1× |
| Q3 FY12 | 9 Feb 2012 | +1.6% | +2.5% | +14.6% | 3.9× |
| Q2 FY12 | 9 Nov 2011 | -3.0% | -11.7% | +4.2% | 0.3× |
| Q1 FY12 | 17 Aug 2011 | -0.9% | -0.2% | -6.2% | 0.5× |
| Q4 FY11 | 3 Jun 2011 | -1.0% | -1.0% | -5.2% | 0.5× |
| Q3 FY11 | 14 Feb 2011 | +0.3% | -6.5% | -7.7% | 1.3× |
| Q2 FY11 | 15 Nov 2010 | -0.5% | +0.6% | -1.4% | 0.6× |
| Q1 FY11 | 31 Jul 2010 | -0.6% | +2.8% | +35.2% | 0.4× |
| Q4 FY10 | 25 Jun 2010 | +3.0% | +9.3% | +4.7% | 2.9× |
| Q3 FY10 | 27 Jan 2010 | +0.2% | +1.8% | +7.4% | 0.5× |
| Q2 FY10 | 29 Oct 2009 | -2.8% | -4.6% | -4.6% | 0.7× |
| Q1 FY10 | 30 Jul 2009 | -4.0% | -4.6% | +31.9% | 0.8× |
| Q4 FY09 | 30 Jun 2009 | -2.7% | -4.3% | -1.8% | 0.6× |
| Q3 FY09 | 27 Jan 2009 | +6.5% | +4.3% | +3.8% | 2.6× |
| Q2 FY09 | 31 Oct 2008 | +9.2% | +18.4% | +20.7% | 1.1× |
| Q1 FY09 | 31 Jul 2008 | -0.7% | +10.9% | +5.5% | 0.7× |
| Q4 FY08 | 30 Jun 2008 | -1.3% | -7.4% | -2.0% | 1.3× |
| Q3 FY08 | 25 Jan 2008 | -3.0% | +1.7% | -8.7% | 0.2× |
| Q2 FY08 | 26 Oct 2007 | -0.2% | +0.6% | +3.1% | 1.0× |
| Q1 FY08 | 26 Jul 2007 | -0.8% | -6.8% | -17.0% | 1.5× |
| Q4 FY07 | 29 Jun 2007 | -6.4% | -11.5% | -19.1% | 1.6× |
| Average | -1.0% | -1.1% | +2.6% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q2 FY27
| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | -17.7% | -4.6% | +5.7% | +15.9% | +5.0% | +6.5% |
| Profit | -34.7% | -9.8% | +19.4% | +26.5% | +7.9% | +6.2% |
Key data
Delivery percentage
Over the last 20 sessions NATCOPHARM settled 50.6% of its traded quantity, which is above average for an NSE equity. Its one-year average is 41.6%, so recent sessions are running 9.1 points higher than usual. The latest session ranks higher than 40% of the 3,603 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
Dividends, deals & holders
Performance returns
| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | -0.93% | +0.48% | +3.71% | -7.20% | -30.66% | +0.20% |
Valuation
Ownership
Quarterly results · consolidated
| Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | |
|---|---|---|---|---|
| Revenue (₹ Cr) | 647.3 | 739.1 | 735.2 | 967.3 |
| YoY chg | +36.3% | -39.5% | -44.7% | -29.0% |
| Net profit (₹ Cr) | 151.3 | 269.0 | 206.5 | 202.6 |
| YoY chg | +14.3% | -33.7% | -57.0% | -60.9% |
| Net margin | 23.4% | 36.4% | 28.1% | 20.9% |
| EPS | 8.46 | 14.96 | 11.53 | 11.31 |
Shareholding over time
By quarter
23 Oct 2026 · promoter 46.22% · public 53.78%- Promoter
- Public and others
- Promoter
- 46.22%
- Public
- 53.78%
- Promoter change
- -3.17 pp
- Filed
- 1 Nov 2026
- FII
- 15.36%
- DII
- 10.82%
- Promoter pledged
- 0.94%
Who the public is
- Mutual funds
- 7.01%
- Insurance
- 3.57%
- FPI
- 15.37%
- Retail ≤ ₹2L
- 19.59%
- HNI > ₹2L
- 3.18%
- NRI
- 1.66%
- Bodies corporate
- 1.50%
- Shareholders
- 4,04,384
+4.76 pp QoQ
-0.23 pp QoQ
-0.62 pp QoQ
-1.05 pp QoQ
-0.04 pp QoQ
-0.06 pp QoQ
-0.09 pp QoQ
+0.1% QoQ
Major holders
As of 23 Oct 2026| Holder | Type | Holding | Shares |
|---|---|---|---|
| V C NANNAPANENI | Promoter · Individual | 14.60% | 2.86Cr |
| TIME CAP PHARMA LABS PRIVATE LIMITED | Promoter · Corporate | 9.23% | 1.81Cr |
| NATSOFT INFORMATION SYSTEMS PVT LTD | Promoter · Corporate | 8.17% | 1.60Cr |
| VENKATA SATYA SWATHI KANTAMANI | Promoter · Individual | 8.15% | 1.60Cr |
| TATA MUTUAL FUND | Mutual fund | 2.58% | 50.57L |
| BELGRAVE INVESTMENT FUND | FPI | 2.42% | 47.45L |
| Vistra ITCL India Limited A/c Neelima Nannapaneni Trust | Promoter · Other | 2.12% | 41.53L |
| LIFE INSURANCE CORPORATION OF INDIA | Insurance | 2.04% | 40.09L |
| DURGA DEVI NANNAPANENI | Promoter · Individual | 1.78% | 34.89L |
| ICICI Prudential | Mutual fund | 1.61% | 31.49L |
Every promoter-group member, and each public holder above 1%, as filed.
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.
Dividends
| Financial year | Payments | Declared | Adjusted |
|---|---|---|---|
| FY2026-27 | 2 | ₹2.75 | ₹2.75 |
| FY2025-26 | 3 | ₹5.00 | ₹5.00 |
| FY2024-25 | 3 | ₹6.00 | ₹6.00 |
| FY2023-24 | 3 | ₹9.50 | ₹9.50 |
| FY2022-23 | 3 | ₹5.50 | ₹5.50 |
| FY2021-22 | 3 | ₹4.50 | ₹4.50 |
| FY2020-21 | 4 | ₹6.25 | ₹6.25 |
| FY2019-20 | 4 | ₹7.00 | ₹7.00 |
| FY2018-19 | 2 | ₹5.00 | ₹5.00 |
| FY2017-18 | 2 | ₹8.25 | ₹8.25 |
| FY2016-17 | 2 | ₹6.75 | ₹6.75 |
| FY2015-16 | 1 | ₹1.25 | ₹1.25 |
| FY2014-15 | 1 | ₹5.00 | ₹1.00 |
| FY2013-14 | 1 | ₹5.00 | ₹1.00 |
| FY2012-13 | 1 | ₹4.00 | ₹0.80 |
| FY2011-12 | 1 | ₹3.00 | ₹0.60 |
| Ex-date | Record date | Declared | Adjusted |
|---|---|---|---|
| 19 Nov 2026 | 19 Nov 2026 | ₹1.25 | ₹1.25 |
| 20 Aug 2026 | — | ₹1.50 | ₹1.50 |
| 18 Feb 2026 | — | ₹1.50 | ₹1.50 |
| 20 Nov 2025 | — | ₹1.50 | ₹1.50 |
| 19 Aug 2025 | — | ₹2.00 | ₹2.00 |
| 18 Feb 2025 | — | ₹1.50 | ₹1.50 |
| 27 Nov 2024 | — | ₹1.50 | ₹1.50 |
| 23 Aug 2024 | — | ₹3.00 | ₹3.00 |
| 26 Feb 2024 | — | ₹1.25 | ₹1.25 |
| 24 Nov 2023 | — | ₹1.25 | ₹1.25 |
| 22 Aug 2023 | — | ₹7.00 | ₹7.00 |
| 21 Feb 2023 | — | ₹1.25 | ₹1.25 |
| 21 Nov 2022 | — | ₹0.75 | ₹0.75 |
| 19 Aug 2022 | — | ₹3.50 | ₹3.50 |
| 24 Feb 2022 | — | ₹2.00 | ₹2.00 |
| 23 Nov 2021 | — | ₹0.50 | ₹0.50 |
| 24 Aug 2021 | — | ₹2.00 | ₹2.00 |
| 22 Feb 2021 | — | ₹1.00 | ₹1.00 |
| 24 Nov 2020 | — | ₹3.00 | ₹3.00 |
| 21 Aug 2020 | — | ₹1.25 | ₹1.25 |
| 26 Jun 2020 | — | ₹1.00 | ₹1.00 |
| 24 Feb 2020 | — | ₹3.50 | ₹3.50 |
| 21 Nov 2019 | — | ₹1.00 | ₹1.00 |
| 22 Aug 2019 | — | ₹1.25 | ₹1.25 |
| 6 Jun 2019 | — | ₹1.25 | ₹1.25 |
| 21 Feb 2019 | — | ₹3.50 | ₹3.50 |
| 20 Aug 2018 | — | ₹1.50 | ₹1.50 |
| 15 Feb 2018 | — | ₹7.00 | ₹7.00 |
| 16 Aug 2017 | — | ₹1.25 | ₹1.25 |
| 23 Feb 2017 | — | ₹6.00 | ₹6.00 |
| 19 Aug 2016 | — | ₹0.75 | ₹0.75 |
| 22 Feb 2016 | — | ₹1.25 | ₹1.25 |
| 24 Feb 2015 | — | ₹5.00 | ₹1.00 |
| 24 Feb 2014 | — | ₹5.00 | ₹1.00 |
| 22 Feb 2013 | — | ₹4.00 | ₹0.80 |
| 22 Feb 2012 | — | ₹3.00 | ₹0.60 |
Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.
Book closures & record dates
NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.
Insider trades
- Insiders net, 30d
- ₹0
- Insiders net, 90d
- ₹0
- Promoters net, 90d
- ₹0
- Insider buyers, 90d
- 0
- Last promoter buy
- 3.9 years ago
- Disclosures on record
- 175
| Broadcast | Person | Side | Shares | Value | Price | Holding before → after | Stake | Regulation |
|---|---|---|---|---|---|---|---|---|
| 11 Mar 2026 | SANJAY NANNAPANENIPromoter | Sell | 70.0K | ₹7.1Cr | 1,017.31 | 2.27L → 1.57L | 0.09%-0.04 pp | 7(2)told 11 Mar 2026 |
| 11 Mar 2026 | SATYA VANI NANNAPANENIPromoter | Sell | 45.0K | ₹4.5Cr | 1,001.33 | 3.80L → 3.35L | 0.19%-0.03 pp | 7(2)told 11 Mar 2026 |
| 1 Oct 2025 | SANJAY NANNAPANENIPromoter | Sell | 1.00L | ₹8.0Cr | 803.05 | 3.27L → 2.27L | 0.13%-0.06 pp | 7(2)told 1 Oct 2025 |
| 17 Sept 2025 | SATYA VANI NANNAPANENIPromoter | Sell | 23.0K | ₹2.0Cr | 857.39 | 4.03L → 3.80L | 0.21%-0.01 pp | 7(2)told 17 Sept 2025 |
| 11 Sept 2025 | SATYA VANI NANNAPANENIPromoter | Sell | 17.1K | ₹1.5Cr | 846.68 | 4.20L → 4.03L | 0.22%-0.01 pp | 7(2)told 11 Sept 2025 |
| 12 Jun 2025 | PRAGNYA RAO DONTHINENIOther | Buy | 100 | ₹86,500 | 865.00 | 303 → 403 | 0.00%0.00 pp | 7(2)told 11 Jun 2025 |
| 31 Dec 2024 | Lakshminarayana BolisettyDirector | Sell | 2.0K | ₹27.8L | 1,391.61 | 2.0K → — | 0.00% | 7(2)told 31 Dec 2024 |
| 31 Dec 2024 | TUMMALA VENKAT RAOEmployee | Sell | 2.5K | ₹34.5L | 1,380.38 | 64.4K → 61.9K | 0.03%-0.00 pp | 7(2)told 30 Dec 2024 |
| 21 Dec 2024 | SADA SIVA RAO. NANNAPANENIEmployee | Sell | 5.0K | ₹73.4L | 1,467.22 | 76.1K → 71.1K | 0.04%-0.00 pp | 7(2)told 20 Dec 2024 |
| 2 Dec 2024 | TUMMALA RAHULOther | Sell | 1.0K | ₹13.5L | 1,352.86 | 1.0K → — | 0.00% | 7(2)told 30 Nov 2024 |
| 28 Nov 2024 | TUMMALA RAHULOther | Sell | 900 | ₹12.2L | 1,359.24 | 1.9K → 1.0K | 0.00%0.00 pp | 7(2)told 28 Nov 2024 |
| 12 Sept 2024 | AMIT SOGANIOther | Sell | 1.5K | ₹24.3L | 1,617.57 | 1.5K → — | 0.00% | 7(2)told 12 Sept 2024 |
| 6 Sept 2024 | SUNIL KOTARUOther | Sell | 1.3K | ₹20.4L | 1,556.62 | 4.3K → 3.0K | 0.00%0.00 pp | 7(2)told 6 Sept 2024 |
| 5 Sept 2024 | G VENKATA RAMANAOther | Sell | 2.0K | ₹30.7L | 1,533.02 | 8.2K → 6.2K | 0.00%0.00 pp | 7(2)told 5 Sept 2024 |
| 2 Sept 2024 | M SUBBA RAOOther | Sell | 20.0K | ₹3.0Cr | 1,514.00 | 55.1K → 35.1K | 0.02%-0.01 pp | 7(3)told 31 Aug 2024 |
| 26 Aug 2024 | DHRUVA KUMAR NANNAPANENIRelative | Sell | 600 | ₹9.4L | 1,560.09 | 1.4K → 775 | 0.00%0.00 pp | 7(2)told 26 Aug 2024 |
| 22 Aug 2024 | N SRILAKSHMIRelative | Sell | 10.0K | ₹1.5Cr | 1,456.13 | 61.0K → 51.0K | 0.03%-0.01 pp | 7(2)told 22 Aug 2024 |
| 21 Aug 2024 | ANILA TPromoter | Sell | 35.0K | ₹5.0Cr | 1,437.46 | 6.00L → 5.65L | 0.32%-0.02 pp | 7(2)told 21 Aug 2024 |
| 21 Aug 2024 | VIDYADHARI TUMMALAPromoter | Sell | 75.0K | ₹10.9Cr | 1,458.75 | 4.42L → 3.67L | 0.21%-0.04 pp | 7(2)told 21 Aug 2024 |
| 21 Aug 2024 | RATNAKUMAR KPromoter | Sell | 38.4K | ₹5.6Cr | 1,460.48 | 88.4K → 50.0K | 0.03%-0.02 pp | 7(2)told 20 Aug 2024 |
| 21 Aug 2024 | RATNAKUMAR KPromoter | Sell | 11.6K | ₹1.7Cr | 1,460.48 | 1.00L → 88.4K | 0.05%-0.01 pp | 7(2)told 20 Aug 2024 |
| 29 Jun 2024 | PULLAREDDY MUDDASANIEmployee | Sell | 500 | ₹5.9L | 1,170.63 | 44.6K → 44.1K | 0.02%-0.00 pp | 7(2)told 29 Jun 2024 |
| 26 Jun 2024 | SANDEEP KURRAOther | Sell | 17 | ₹20,400 | 1,200.00 | 17 → — | 0.00% | 7(2)told 26 Jun 2024 |
| 26 Jun 2024 | VENKATA SREENIVASABABU KURRAEmployee | Sell | 2.4K | ₹28.9L | 1,197.94 | 2.4K → — | 0.00% | 7(2)told 26 Jun 2024 |
| 26 Jun 2024 | SUNIL KOTARUEmployee | Sell | 840 | ₹10.1L | 1,202.40 | 5.2K → 4.3K | 0.00%0.00 pp | 7(2)told 25 Jun 2024 |
| 26 Jun 2024 | TUMMALA VENKAT RAOEmployee | Sell | 400 | ₹4.8L | 1,207.30 | 64.8K → 64.4K | 0.04%-0.00 pp | 7(2)told 26 Jun 2024 |
| 25 Jun 2024 | POTLURI SIVA RAMA KRISHNA PRASADDirector | Sell | 5.0K | ₹60.0L | 1,200.00 | 46.1K → 41.1K | 0.02%-0.00 pp | 7(2)told 25 Jun 2024 |
| 21 Jun 2024 | PRAVEEN CHOWDARY MYNENIEmployee | Sell | 999 | ₹11.7L | 1,174.70 | 10.4K → 9.4K | 0.00%0.00 pp | 7(2)told 20 Jun 2024 |
| 4 Jun 2024 | PRATIMA JAINEmployee | Sell | 1.4K | ₹13.7L | 998.90 | 1.4K → — | 0.00% | 7(2)told 4 Jun 2024 |
| 29 Dec 2023 | LINGA RAO DDirector | Sell | 10.0K | ₹80.0L | 799.99 | 64.2K → 54.2K | 0.03%-0.01 pp | 7(2)told 29 Dec 2023 |
| 28 Dec 2023 | TUMMALA RAHULOther | Sell | 100 | ₹81,275 | 812.75 | 2.0K → 1.9K | 0.00%0.00 pp | 7(3)told 28 Dec 2023 |
| 23 Dec 2023 | LAKSHMI NARAYANA AREEmployee | Sell | 1.5K | ₹12.0L | 800.00 | 12.6K → 11.1K | 0.00%0.00 pp | 7(2)told 23 Dec 2023 |
| 15 Dec 2023 | PATIL CHANDRASEKHARA REDDYEmployee | Sell | 1.1K | ₹8.5L | 784.00 | 1.1K → 50 | 0.00%0.00 pp | 7(2)told 15 Dec 2023 |
| 13 Dec 2023 | PATIL CHANDRASEKHARA REDDYEmployee | Sell | 4.1K | ₹32.2L | 780.82 | 5.3K → 1.1K | 0.00%0.00 pp | 7(2)told 12 Dec 2023 |
| 11 Dec 2023 | POTLURI SIVA RAMA KRISHNA PRASADDirector | Sell | 10.0K | ₹79.3L | 792.91 | 56.1K → 46.1K | 0.03%-0.01 pp | 7(2)told 11 Dec 2023 |
| 4 Dec 2023 | JAYA POTLURIOther | Sell | 1.7K | ₹13.1L | 774.57 | 1.7K → — | 0.00% | 7(3)told 4 Dec 2023 |
| 4 Dec 2023 | NDL INFRATECH PVT LTDPromoter | Sell | 300 | ₹2.3L | 771.40 | 94.0K → 93.8K | 0.05%-0.00 pp | 7(2)told 4 Dec 2023 |
| 22 Nov 2023 | LAKSHMI NARAYANA AREEmployee | Sell | 2.0K | ₹15.7L | 784.14 | 14.6K → 12.6K | 0.01%-0.00 pp | 7(2)told 22 Nov 2023 |
| 4 Oct 2023 | VANAJA MUDDASANIRelative | Sell | 900 | ₹8.0L | 891.56 | 5.2K → 4.3K | 0.00%0.00 pp | 7(2)told 3 Oct 2023 |
| 6 Sept 2023 | PURANDHAR TOther | Sell | 25.0K | ₹2.3Cr | 900.01 | 2.59L → 2.34L | 0.13%-0.01 pp | 7(3)told 6 Sept 2023 |
| 6 Sept 2023 | ANILA TPromoter | Sell | 30.0K | ₹2.7Cr | 904.85 | 6.30L → 6.00L | 0.33%-0.02 pp | 7(2)told 6 Sept 2023 |
| 6 Sept 2023 | ANANDA BABU TPromoter | Sell | 60.0K | ₹5.4Cr | 903.74 | 4.73L → 4.13L | 0.23%-0.03 pp | 7(2)told 6 Sept 2023 |
| 22 Feb 2023 | NITEESHRAO MADHAVARAMOther | Buy | 10 | ₹5,361 | 536.10 | 125 → 135 | 0.00%0.00 pp | 7(3)told 22 Feb 2023 |
| 20 Feb 2023 | NITEESHRAO MADHAVARAMOther | Buy | 55 | ₹29,150 | 530.00 | 70 → 125 | 0.00%0.00 pp | 7(3)told 20 Feb 2023 |
| 20 Feb 2023 | PRAGNYA RAO DONTHINENIOther | Buy | 303 | ₹1.6L | 530.41 | — → 303 | 0.00% | 7(3)told 20 Feb 2023 |
| 20 Dec 2022 | V C NANNAPANENIPromoter | Buy | 9.1K | ₹49.8L | 550.80 | 2.26Cr → 2.26Cr | 12.38%+0.00 pp | 7(2)told 20 Dec 2022 |
| 2 Dec 2022 | NATSOFT INFORMATION SYSTEMPS PVT LTDPromoter | Buy | 17.4K | ₹99.4L | 571.49 | 1.58Cr → 1.58Cr | 8.65%+0.01 pp | 7(2)told 2 Dec 2022 |
| 1 Dec 2022 | V C NANNAPANENIPromoter | Buy | 8.9K | ₹49.9L | 562.15 | 2.26Cr → 2.26Cr | 12.38%+0.00 pp | 7(2)told 1 Dec 2022 |
| 29 Mar 2022 | NDL INFRATECH PVT LTDPromoter | Buy | 300 | ₹2.6L | 870.32 | 93.8K → 94.0K | 0.05%+0.00 pp | 7(2)told 28 Mar 2022 |
| 4 Mar 2022 | PULLAREDDY MUDDASANIEmployee | Buy | 500 | ₹4.0L | 806.60 | 38.1K → 38.6K | 0.02%+0.00 pp | 7(2)told 3 Mar 2022 |
| 4 Mar 2022 | BIKKUMALLA SRINIVASA RAOEmployee | Sell | 350 | ₹3.1L | 884.00 | 350 → — | 0.00% | 7(2)told 4 Mar 2022 |
| 25 Aug 2021 | ADINARAYANA MADINEEDIKMP | Buy | 340 | ₹3.1L | 900.97 | 40.7K → 41.0K | 0.02%+0.00 pp | 7(2)told 25 Aug 2021 |
| 25 Aug 2021 | SUSEELA PINNAMANENIRelative | Buy | 246 | ₹2.2L | 894.01 | 8.8K → 9.0K | 0.00%0.00 pp | 7(2)told 25 Aug 2021 |
| 25 Aug 2021 | SRILAKSHMI PINNAMANENIRelative | Buy | 150 | ₹1.3L | 899.62 | 17.9K → 18.0K | 0.01%+0.00 pp | 7(2)told 25 Aug 2021 |
| 23 Aug 2021 | TUMMALA VENKAT RAOEmployee | Buy | 1.0K | ₹9.1L | 910.52 | 63.8K → 64.8K | 0.03%+0.00 pp | 7(2)told 23 Aug 2021 |
SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.
How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session
Filings
CSVBulk & block deals · 26 Nov 2025
CSV| Date | Deal | Client | Quantity | Price | Value |
|---|---|---|---|---|---|
| 26 Nov 2025 | Sell · bulk | GRAVITON RESEARCH CAPITAL LLP | 11.99L | 904.93 | ₹108.5Cr |
| 26 Nov 2025 | Buy · bulk | GRAVITON RESEARCH CAPITAL LLP | 11.99L | 904.19 | ₹108.4Cr |
| 24 Apr 2025 | Sell · bulk | GRAVITON RESEARCH CAPITAL LLP | 17.85L | 930.19 | ₹166.0Cr |
| 24 Apr 2025 | Buy · bulk | GRAVITON RESEARCH CAPITAL LLP | 17.85L | 929.71 | ₹165.9Cr |
| 14 Feb 2025 | Sell · bulk | GRAVITON RESEARCH CAPITAL LLP | 9.72L | 891.03 | ₹86.6Cr |
| 14 Feb 2025 | Buy · bulk | GRAVITON RESEARCH CAPITAL LLP | 9.72L | 890.86 | ₹86.6Cr |
| 3 Oct 2022 | Sell · block | ISHARES CORE EMERGING MARKETS MAURITIUS CO | 1.88L | 605.80 | ₹11.4Cr |
| 3 Oct 2022 | Buy · block | ISHARES CORE MSCI EMERGING MARKETS ETF | 1.88L | 605.80 | ₹11.4Cr |
| 3 Oct 2022 | Sell · block | ISHARES INDIA SC MAURITIUS COMPANY | 22.2K | 605.80 | ₹1.3Cr |
| 3 Oct 2022 | Buy · block | ISHARES MSCI INDIA SMALL-CAP ETF | 22.2K | 605.80 | ₹1.3Cr |
| 20 Jun 2014 | Buy · bulk | MV SCIF MAURITIUS | 1.75L | 1,149.56 | ₹20.1Cr |
| 29 Jul 2013 | Sell · bulk | MERRILL LYNCH CAPITAL MARKET ESPANA SA SV | 2.00L | 589.55 | ₹11.8Cr |
A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.
Takeover-code disclosures
Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.
Every stock on this session →Short selling, lending & margin
Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.
Exchange surveillance
No surveillance measure applies to NATCOPHARM.
Price band: 20% · not in the F&O ban.
From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.
Every stock on this session →Financials · quarterly statement
| Q3 FY24 | Q4 FY24A | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25A | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26A | Q1 FY27 | Q2 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 758.6 | 1,068.3 | 1,362.6 | 1,371.1 | 474.8 | 1,221.0 | 1,328.9 | 1,363.0 | 647.3 | 739.1 | 735.2 | 967.3 | |
| Other income | 37.0 | 42.0 | 48.1 | 63.8 | 176.3 | 66.3 | 61.7 | 100.0 | 58.1 | 77.8 | 59.2 | 52.1 | |
| Total income | 795.6 | 1,110.3 | 1,410.7 | 1,434.9 | 651.1 | 1,287.3 | 1,390.6 | 1,463.0 | 705.4 | 816.9 | 794.4 | 1,019.4 | |
| Total expenses | 539.3 | 632.7 | 607.1 | 616.7 | 487.4 | 781.4 | 818.7 | 849.3 | 544.3 | 672.8 | 608.8 | 776.2 | |
| └ Finance costs | 4.6 | 6.2 | 5.2 | 4.1 | 4.4 | 10.2 | 3.2 | 13.1 | 9.5 | 10.9 | 13.0 | 17.6 | |
| └ Depreciation | 44.2 | 55.5 | 44.1 | 45.8 | 47.0 | 98.3 | 57.6 | 52.4 | 46.2 | 50.4 | 47.1 | 49.2 | |
| Profit before tax | 256.3 | 477.6 | 803.6 | 818.2 | 163.7 | 505.9 | 571.9 | 613.7 | 161.1 | 144.1 | 185.6 | 243.2 | |
| Tax expense | 43.6 | 91.3 | 135.1 | 141.7 | 31.3 | 99.9 | 91.6 | 95.8 | 20.7 | (89.2) | 63.4 | 69.8 | |
| Net profit | 212.7 | 386.3 | 668.5 | 676.5 | 132.4 | 406.0 | 480.3 | 517.9 | 151.3 | 269.0 | 206.5 | 202.6 | |
| EPS | 11.88 | 21.56 | 37.32 | 37.81 | 7.43 | 22.70 | 26.84 | 28.94 | 8.46 | 14.96 | 11.53 | 11.31 | |
| Net margin | 28.04% | 36.16% | 49.06% | 49.34% | 27.89% | 33.25% | 36.14% | 38.00% | 23.37% | 36.40% | 28.09% | 20.94% | |
| PBT margin | 33.79% | 44.71% | 58.98% | 59.67% | 34.48% | 41.43% | 43.04% | 45.03% | 24.89% | 19.50% | 25.24% | 25.14% | |
| Tax rate | 17.01% | 19.12% | 16.81% | 17.32% | 19.12% | 19.75% | 16.02% | 15.61% | 12.85% | -61.90% | 34.16% | 28.70% |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 13 Nov 2026.
Balance sheet & cash flow · half-yearly
Balance sheet
| FY23 | H1 FY24 | FY24 | H1 FY25 | FY25 | H1 FY26 | FY26 | H1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 5,657.4 | 6,254.0 | 6,906.3 | 8,244.7 | 8,630.8 | 10,430.1 | 11,073.7 | 11,798.8 | |
| Current assets | 3,000.3 | 3,349.7 | 4,023.5 | 5,001.5 | 5,270.0 | 6,966.7 | 5,052.3 | 4,234.9 | |
| └ Cash & equivalents | 131.9 | 104.0 | 70.4 | 104.6 | 120.0 | 103.5 | 198.9 | 138.5 | |
| └ Other bank balances | 414.4 | 615.5 | 882.5 | 1,457.5 | 2,056.0 | 2,586.7 | 1,352.0 | 930.5 | |
| └ Current investments | 305.0 | 299.5 | 443.5 | 474.4 | 320.8 | 514.1 | 578.2 | 448.3 | |
| └ Trade receivables | 856.1 | 1,119.8 | 1,188.9 | 1,435.7 | 1,246.6 | 1,718.9 | 881.2 | 803.4 | |
| └ Inventories | 742.9 | 709.8 | 700.5 | 774.6 | 765.8 | 818.0 | 908.5 | 1,006.2 | |
| Total equity | 4,873.8 | 5,293.5 | 5,853.1 | 7,156.8 | 7,612.3 | 8,654.2 | 9,221.1 | 9,764.7 | |
| └ Attributable to owners | 4,873.8 | 5,293.5 | 5,853.1 | 7,149.9 | 7,607.0 | 8,649.8 | 9,221.1 | 9,764.7 | |
| └ Non-controlling interest | — | — | — | 6.9 | 5.3 | 4.4 | 0.0 | — | |
| └ Share capital | 36.5 | 35.8 | 35.8 | 35.8 | 35.8 | 35.8 | 35.8 | 35.8 | |
| Borrowings | 165.0 | 238.8 | 363.2 | 201.0 | 273.1 | 252.8 | 706.4 | 1,026.7 | |
| └ Current | 165.0 | 238.8 | 363.2 | 201.0 | 273.1 | 252.8 | 606.4 | 1,026.7 | |
| └ Non-current | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 0.0 | |
| Trade payables | 263.8 | 366.1 | 235.5 | 314.4 | 274.9 | 512.6 | 409.3 | 424.4 | |
| Current liabilities | 683.1 | 878.3 | 972.8 | 1,008.7 | 943.5 | 1,700.0 | 1,680.9 | 1,950.3 | |
| Total liabilities | 783.6 | 960.5 | 1,053.2 | 1,087.9 | 1,018.5 | 1,775.9 | 1,852.6 | 2,034.1 | |
| Net debt | (686.3) | (780.2) | (1,033.2) | (1,835.5) | (2,223.7) | (2,951.5) | (1,422.7) | (490.6) | |
| Debt / equity | 0.03 | 0.05 | 0.06 | 0.03 | 0.04 | 0.03 | 0.08 | 0.11 | |
| Current ratio | 4.39 | 3.81 | 4.14 | 4.96 | 5.59 | 4.10 | 3.01 | 2.17 |
Cash flow, year to date
| FY23 | H1 FY24 | FY24 | H1 FY25 | FY25 | H1 FY26 | FY26 | H1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 849.1 | 632.3 | 1,211.6 | 1,137.0 | 1,696.8 | 1,190.6 | 1,768.3 | 165.0 | |
| └ Capex | (205.6) | (166.3) | (358.7) | (240.1) | (511.6) | (184.0) | (391.1) | (307.5) | |
| Free cash flow | 643.5 | 466.0 | 852.9 | 896.9 | 1,185.2 | 1,006.6 | 1,377.2 | (142.5) | |
| Investing cash flow | (477.1) | (347.8) | (1,032.7) | (881.7) | (1,414.5) | (1,188.7) | (2,142.9) | (504.8) | |
| Financing cash flow | (363.0) | (314.4) | (246.9) | (219.1) | (210.7) | (76.5) | 297.5 | 261.4 | |
| └ Dividends paid | (100.4) | (125.5) | (170.8) | (53.8) | (107.8) | (36.2) | (90.2) | (27.1) | |
| └ Buybacks | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Net change in cash | 9.0 | (29.9) | (68.0) | 36.2 | 71.6 | (74.6) | (77.1) | (78.4) |
From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.
Announcements & board meetings
As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.
Every stock on this session →NATCOPHARM at a glance
- NATCOPHARM closed at ₹814.3 on 20 Nov 2026, -0.93% on the day, +0.2% over one year, 33.6% below its 52-week high of ₹1,226.8.
- Delivery was 48.3% of traded quantity on 20 Nov 2026, the 40th percentile of its own 3,603 sessions with a reading (20-session average 50.6%, 1-year average 41.6%).
- Market capitalisation is ₹15,974 crore at a trailing P/E of 19.3 (trailing EPS ₹42.23).
- Q2 FY27 results (consolidated, filed 13 Nov 2026): revenue ₹967 crore (-29.0% year on year), net profit ₹203 crore (-60.9%); the price moved +0.2% on the first session after.
- Promoters held 46.22% at 23 Oct 2026, down 3.17 percentage points on the previous filing, with 0.94% of promoter shares pledged.
- Q3 FY27 results are expected between 9 Feb 2027 and 14 Feb 2027, going by past filing dates — an estimate, not an announcement.
About
Sector history
- to 16 Aug 2026Index industry · Healthcare
- from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
NSE’s own classification, by the snapshot it changed on.
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.
More in Pharmaceuticals & Biotechnology
- DIDIVISLABDivi's Laboratories Limited11,180.50+0.02%
- LALAURUSLABSLaurus Labs Limited2,294.60-0.49%
- SUSUNPHARMASun Pharmaceutical Industries Limited1,884.90-0.79%
- ACACUTAASAcutaas Chemicals Limited3,833.50-3.61%
- SASAILIFESai Life Sciences Limited1,800.70+0.69%
- PPPPLPHARMAPiramal Pharma Limited239.30-0.15%
- DRDRREDDYDr. Reddy's Laboratories Limited1,390.20-0.76%
- GLGLENMARKGlenmark Pharmaceuticals Limited2,648.00+1.51%
- AUAUROPHARMAAurobindo Pharma Limited1,799.00-0.37%
- CICIPLACipla Limited1,415.00-0.25%
- ZYZYDUSLIFEZydus Lifesciences Limited1,200.00-0.24%
- MAMANKINDMankind Pharma Limited2,665.00+1.37%
All Pharmaceuticals & Biotechnology stocks on the NSEAll Healthcare stocks on the NSE